HABIT-ILE + FST in Children With SMA

Study Identifier:
25-429
ClinicalTrials.gov Identifier:
NCT07223320
EudraCT Identifier:
N/A
EU CT Number:
N/A
Sponsor:
Teachers College, Columbia University
Active, not recruiting

Study Details

Medical Condition
  • All Spinal Muscular Atrophies
Study Drug
    Date
    Oct 2025 - Dec 2026
    Patient Requirements
    Sex: Female & Male
    Age: 5 - 17 Years
    Requirements Information
    Inclusion and Exclusion Criteria
    Inclusion Criteria
    • Diagnosis of SMA
    • Able to participate in all pre and post intervention assessments
    • Able to understand and speak English
    • Able to understand directions (no significant cognitive delay or serious behavioral issues that would limit participation)
    • Receiving a stable dose of disease-modifying therapies for at least 6 months prior to enrollment.
    Exclusion Criteria
    • Orthopedic surgery within the last year (confound)
    • Initiation of any new pharmaceutical treatment during the study period
    • Participation in a clinical trial of an investigational therapy

    Protocol Summary

    This single-arm pilot study will assess the feasibility and preliminary effectiveness of an intensive motor skill intervention (HABIT-ILE) combined with functional strength training (FST) in children with SMA who are receiving disease-modifying therapies. Participants will attend one 6-hour HABIT-ILE + FST session each weekend (Saturday or Sunday) for 15 weeks, for a total of 90 hours of training. Feasibility will be evaluated through questionnaires, and effectiveness through standardized motor function assessments.

    Trial Locations

    Location
    Status
    Location
    Center for Cerebral Palsy Research, Teachers College, Columbia University
    New York, New York, United States, 10027
    Status
    N/A

    Contact Cure SMA

    User Information

    If you have general questions regarding clinical trials or would like to be added to the Cure SMA mailing list to receive communications regarding future registries, studies, or clinical trials in SMA, please fill out the form below. Fields marked with an asterisk (*) are mandatory.

    • Disability Advocate who does not have SMA
    • I am a healthcare provider
    • I am a researcher
    • I have no direct connection to SMA
    • I have SMA
    • I lost a child to SMA
    • My child has SMA
    • Someone close to me has/had SMA
    • Australia
    • Belgium
    • Brazil
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Estonia
    • France
    • Germany
    • Greece
    • Hong Kong
    • Hungary
    • India
    • Ireland
    • Israel
    • Italy
    • Japan
    • Lebanon
    • Malaysia
    • Mexico
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Puerto Rico
    • Qatar
    • Republic of Korea
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam
    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.